Conatus Pharmaceuticals Inc. (CNAT) has 13 open-market insider trades by 13 insiders since 2013. The most active filer is Venture Partners Llp Advent, 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Venture Partners Llp Advent | 10% | — | 1 | $2.1M | 2013-07-30 |
| Shahzad Malik | Dir10% | — | 1 | $2.1M | 2013-07-30 |
| Gilde Healthcare Ii U.a. Cooperative | 10% | — | 1 | $1.8M | 2013-07-30 |
| Marc Olivier Perret | Dir10% | — | 1 | $1.8M | 2013-07-30 |
| James Paul Scopa | Dir | — | 1 | $1.8M | 2013-07-30 |
| Todd Foley | 10% | — | 1 | $1.8M | 2013-07-30 |
| BioVentures Iv Llc Mpm | 10% | — | 1 | $1.8M | 2013-07-30 |
| Louis P. Lacasse | Dir | — | 1 | $1.4M | 2013-07-30 |
| Ventures Iii Lp Aberdare | 10% | — | 1 | $1.2M | 2013-07-30 |
| Paul H. Klingenstein | Dir | — | 1 | $1.2M | 2014-02-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Daniel L. Kisner | Director | Buy | $23K | 2015-04-08 |
| Todd Foley | 10% | Buy | $1.8M | 2013-07-30 |
| David F. Hale | Director | Buy | $28K | 2013-07-30 |
| Shahzad Malik | Director & 10% | Buy | $2.1M | 2013-07-30 |
| Shahzad Malik | Director & 10% | Sell | $6K | 2013-07-30 |
| Steven J. Mento | President & Director | Buy | $152K | 2013-07-30 |
Companies that share insiders with CNAT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Paul H. Klingenstein | Director & 10% | Buy | $1.2M | 2013-07-30 |
| Paul H. Klingenstein | Director & 10% | Sell | $6K | 2013-07-30 |
| Marc Olivier Perret | Director & 10% | Buy | $1.8M | 2013-07-30 |
| Marc Olivier Perret | Director & 10% | Sell | $4K | 2013-07-30 |
| Louis P. Lacasse | Director | Buy | $1.4M | 2013-07-30 |